Aberdeen-based Opportunity North East (ONE) is launching its third dedicated accelerator programme in a bid to double the size of the high-growth life sciences company cluster.
To date, 14 people developing nine businesses have been supported by ONE Life Sciences accelerators
Applications are now being accepted for the new accelerator, which starts in March, that will support up to eight pre-start or early-stage life sciences businesses.
Fully funded by ONE and delivered by BioCity, the programme uses start-up methodology and evidence-based entrepreneurship to translate research and ideas into business that can bring new therapies, products and digital solutions to market.
The eight-week accelerator is for researchers, academics, clinicians and potential entrepreneurs with ideas and based in North East Scotland.
Professor Stephen Logan, chair of the ONE Life Sciences sector board, said: “Interest in new life sciences and healthcare therapies, products and solutions has never been higher. There is a wealth of ideas and innovation with North East Scotland’s research, clinical and academic communities.
“The ONE Life Sciences Accelerator equips people with the knowledge and tools to commercialise innovation at pace.
“The programme directly supports the sector ambition to double the size of the region’s company cluster, anchor high-value businesses in Aberdeen and create new, high-quality jobs in life sciences as part of regional economic recovery and growth.
“It continues ONE’s investment in making Aberdeen a drive for value creation in the national health economy.”